Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
262 Leser
Artikel bewerten:
(1)

Slate Campaigns: Software companies' "smokescreen" complaint investigation against Education Software Solutions dropped by CMA

Finanznachrichten News

LONDON, Aug. 29, 2024 /PRNewswire/ -- Education Software Solutions ("ESS") believes that complaints from third parties, including two of its competitors, which sparked a Competition and Markets Authority ("CMA") investigation into the process used to transfer data from ESS' School Information Management System ("SIMS"), were vexatious and a smokescreen for the continued unlawful use of ESS' intellectual property by these competitors.

The investigation, closed by the CMA without action against ESS, was prompted by competitors who claimed that there was no viable alternative to copying SIMS databases, containing over 1.5 million lines of ESS program code, when transferring school data from SIMS to their own systems.

For more than a decade ESS has provided a safe and authorised method to transfer data from SIMS through the SIMS Application Programming Interfaces ("APIs"). The APIs preserve the integrity of data extracted from SIMS and are widely used with over 5 billion API calls being made in an average month. Given the availability of these APIs there is no justification for ESS' competitors copying SIMS databases or inducing ESS' customers to do so on their behalf. ESS was and is entitled to object to the unlawful use of its intellectual property and to take action against anyone infringing its intellectual property rights.

ESS wrote to certain competitors and schools in December 2023 objecting to the unsafe and unlawful use of SIMS databases to undertake data transfers, reminding them that the APIs and the SIMS Report Generator are the only safe and ESS authorised means for extracting data from SIMS. In response a number of these competitor complained to the CMA, which began its investigation. Six months on, that investigation has been closed, with the CMA acknowledging that (as ESS had said all along) the APIs provide an entirely proper, and in the CMA's words, 'less burdensome' and 'less error prone' method of data extraction than the use of copies of the SIMS database.

Commenting on this decision, Lewis Alcraft, Group Chief Executive of ESS said:

"Certain of our competitors complained to the CMA that the SIMS APIs were too 'complex, time consuming and error prone' to be usable. That this was untrue is now evident from the fact that these same competitors are now using, or proposing to use, these APIs to undertake migrations, a method which in the words of the CMA is 'less burdensome' and 'less error prone' than using copies of the SIMS database. We hope that everyone now sees that these complaints were a smokescreen for the continued unlawful use of ESS' intellectual property."

ESS is considering what action should be taken regarding any misuse of its intellectual property now that the CMA's investigation has been closed. ESS has no wish to impede schools from switching to alternative suppliers provided this is done lawfully. To that end, ESS calls upon any school that intends to transfer data to a new supplier not to be persuaded into handing over backup copies of the SIMS database as part of this exercise, noting that to do so would be a breach of the school's licensing agreement with ESS. Schools should instead insist that any new supplier uses the SIMS APIs.

Cision View original content:https://www.prnewswire.co.uk/news-releases/software-companies-smokescreen-complaint-investigation-against-education-software-solutions-dropped-by-cma-302234159.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.